Cigna director Neesha Hathi granted 782 shares

Hathi Neesha reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Hathi Neesha reported acquisition or exercise transactions in this Form 4 filing.

Cigna Group director Neesha Hathi received a grant of 782 shares of common stock as compensation. The shares were awarded at a stated price of $0.0000 per share, indicating a non-cash grant rather than an open-market purchase. Following this award, Hathi directly holds 4,151 Cigna Group shares.

Insider Trade Summary

Grant/Award: 782 shares

Grant/Award 1 txn

Insider Hathi Neesha

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, $.01 Par Value	782	$0.00	$0.00

Holdings After Transaction: Common Stock, $.01 Par Value — 4,151 shares (Direct)

Key Figures

Shares granted: 782 shares Grant price per share: $0.0000 per share Total shares after transaction: 4,151 shares

3 metrics

Shares granted 782 shares Common Stock grant on 2026-04-22

Grant price per share $0.0000 per share Equity award, non-cash purchase

Total shares after transaction 4,151 shares Director’s direct holdings after grant

Key Terms

Grant, award, or other acquisition, Common Stock, $.01 Par Value, Form 4, non-derivative

4 terms

Grant, award, or other acquisition financial

"Transaction code A indicates a grant, award, or other acquisition."

Common Stock, $.01 Par Value financial

"Security title is Common Stock, $.01 Par Value for this award."

Form 4 regulatory

"The insider transaction is reported on SEC Form 4."

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

non-derivative financial

"The filing classifies this as a non-derivative stock transaction."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Cigna Group (CI) disclose about director Neesha Hathi?

Cigna Group reported that director Neesha Hathi received a grant of 782 shares of common stock. This award increased her direct holdings to 4,151 shares and reflects routine equity-based compensation rather than an open-market stock purchase or sale.

How many Cigna Group (CI) shares were granted to Neesha Hathi?

Neesha Hathi was granted 782 shares of Cigna Group common stock. These shares were recorded at a price of $0.0000 per share, indicating a compensatory grant, and raised her total direct ownership to 4,151 shares after the transaction was completed.

Was Neesha Hathi’s Cigna (CI) transaction a market buy or sell?

The transaction was not a market buy or sell. It is coded as a grant, award, or other acquisition at $0.0000 per share, meaning Hathi received 782 Cigna common shares as compensation rather than purchasing or selling them on the open market.

What is Neesha Hathi’s Cigna Group (CI) share ownership after the grant?

After receiving the 782-share grant, Neesha Hathi directly owns 4,151 shares of Cigna Group common stock. This figure reflects her total direct holdings reported in the Form 4 filing, giving investors a clear snapshot of her current equity stake.

What does transaction code A mean in Cigna (CI) director Neesha Hathi’s filing?

Transaction code A in the Form 4 indicates a grant, award, or other acquisition of stock. For Neesha Hathi, this means the 782 Cigna shares were received as an equity award, not purchased in the market, consistent with typical director compensation practices.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/24/2026 - 04:58 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hathi Neesha

(Last) (First) (Middle)

900 COTTAGE GROVE ROAD

(Street)

BLOOMFIELD CONNECTICUT 06002

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cigna Group [ CI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $.01 Par Value	04/22/2026		A		782	A	$0	4,151	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

	Tyler Gratton, attorney-in-fact	04/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)